Ownership and Security. The Licensed IP shall be treated as property of Filament, and shall be used, securely stored and accounted for in accordance with Good Clinical Practice. Any unused Materials of End-Product shall be destroyed or returned to Filament.
Appears in 4 contracts
Samples: License Agreement (1427702 B.C. LTD), License Agreement (Psyence Biomedical Ltd.), License Agreement (1427702 B.C. LTD)
